Mutations in progranulin gene (GRN) are the most common cause of autosomal dominant familial frontotemporal lobar degeneration (FTLD). In addition, GRN variability influences the risk to develop the disease in non-carriers (sporadic FTLD). We evaluated progranulin gene (GRN) promoter methylation levels in peripheral blood mononuclear cells isolated from 38 patients with sporadic FTLD compared with 38 controls, and correlate them with GRN mRNA expression rate. The percentage of methylation of the GRN promoter was increased in patients with FTLD compared with controls (61.5 vs. 46.3 %, P < 0.001). A trend towards decreased GRN relative expression was observed in patients compared with controls (threefold decrease over controls, P > 0.05), together with a negative correlation between the degree of GRN promoter methylation and mRNA GRN levels (rho = -0.1, P > 0.05). GRN promoter methylation was not correlated with age. In conclusion, the degree of methylation of the GRN promoter is increased in patients with FTLD as compared with controls, likely leading to a decreased expression of GRN.

Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration / D. Galimberti, C. D'Addario, B. Dell'Osso, C. Fenoglio, A. Marcone, C. Cerami, S.F. Cappa, M.C. Palazzo, B. Arosio, D. Mari, M. Maccarrone, N. Bresolin, A.C. Altamura, E. Scarpini. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 34:6(2013 Jun), pp. 899-903.

Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration

D. Galimberti;B. Dell'Osso;B. Arosio;D. Mari;N. Bresolin;A.C. Altamura;E. Scarpini
2013

Abstract

Mutations in progranulin gene (GRN) are the most common cause of autosomal dominant familial frontotemporal lobar degeneration (FTLD). In addition, GRN variability influences the risk to develop the disease in non-carriers (sporadic FTLD). We evaluated progranulin gene (GRN) promoter methylation levels in peripheral blood mononuclear cells isolated from 38 patients with sporadic FTLD compared with 38 controls, and correlate them with GRN mRNA expression rate. The percentage of methylation of the GRN promoter was increased in patients with FTLD compared with controls (61.5 vs. 46.3 %, P < 0.001). A trend towards decreased GRN relative expression was observed in patients compared with controls (threefold decrease over controls, P > 0.05), together with a negative correlation between the degree of GRN promoter methylation and mRNA GRN levels (rho = -0.1, P > 0.05). GRN promoter methylation was not correlated with age. In conclusion, the degree of methylation of the GRN promoter is increased in patients with FTLD as compared with controls, likely leading to a decreased expression of GRN.
Frontotemporal lobar degeneration (FTLD); Progranulin (GRN); Methylation; Peripheral mononuclear cells (PBMC); Expression
Settore MED/09 - Medicina Interna
14-lug-2012
Article (author)
File in questo prodotto:
File Dimensione Formato  
Neurol SCI Progranulin gene (GRN).pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 246.52 kB
Formato Adobe PDF
246.52 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
art%3A10.1007%2Fs10072-012-1151-5.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 227.62 kB
Formato Adobe PDF
227.62 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/215865
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 20
social impact